Valuation: ResMed, Inc.

Market Cap 29.25B 25.56B 23.58B 21.74B 40.97B 2,816B 41.88B 282B 111B 1,379B 110B 107B 4,748B P/E 2026 *
19.2x
P/E 2027 * 17.4x
Enterprise Value 28.46B 24.87B 22.95B 21.16B 39.88B 2,741B 40.76B 274B 108B 1,342B 107B 105B 4,621B EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.61x
Free-Float
75.61%
Yield 2026 *
1.2%
Yield 2027 * 1.3%
1 day-1.87%
1 week-2.36%
Current month+2.14%
1 month+6.85%
3 months-12.74%
6 months-21.38%
Current year-17.36%
1 week 190.25
Extreme 190.25
203.88
1 month 187.01
Extreme 187.01
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
7/7/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
8/6/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
1/6/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.88%-2.36%-22.37%-9.84% 29.25B
-1.90%+1.16%+25.46%+1.51% 202B
-0.94%+1.96%+4.19%-14.64% 145B
-13.06%-14.35%-32.50%-1.54% 142B
-1.86%-2.18%-58.15%-16.76% 66.32B
-2.17%-6.86%+12.74%-7.30% 50.58B
-0.11%+1.53%-24.62%-31.81% 44.81B
-2.88%-1.39%+13.80%+11.98% 38.44B
-2.16%-1.70%+24.62%+37.13% 37.13B
-4.25%-2.43%-17.20%-22.25% 29.89B
Average -3.09%+0.67%-7.40%-5.35% 78.59B
Weighted average by Cap. -3.77%+1.63%-3.72%-5.16%

Financials

2026 *2027 *
Net sales 5.65B 4.94B 4.56B 4.2B 7.92B 544B 8.09B 54.46B 21.42B 266B 21.22B 20.75B 917B 6.02B 5.26B 4.86B 4.48B 8.44B 580B 8.63B 58.07B 22.84B 284B 22.62B 22.13B 978B
Net income 1.55B 1.35B 1.25B 1.15B 2.17B 149B 2.21B 14.91B 5.86B 72.94B 5.81B 5.68B 251B 1.67B 1.46B 1.35B 1.24B 2.34B 161B 2.39B 16.11B 6.34B 78.82B 6.28B 6.14B 271B
Net Debt -783M -685M -632M -582M -1.1B -75.44B -1.12B -7.55B -2.97B -36.95B -2.94B -2.88B -127B -1.46B -1.27B -1.17B -1.08B -2.04B -140B -2.09B -14.04B -5.52B -68.71B -5.47B -5.35B -237B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
18/07/26 USD 199.09 -1.81% 487,615
16/07/26 USD 202.76 +2.11% 1,019,540
15/07/26 USD 198.57 +2.88% 1,208,785
14/07/26 USD 193.01 -2.77% 1,622,359
13/07/26 USD 198.50 -2.63% 2,161,420
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
202.76USD
Average target price
249.40USD
Spread / Average Target
+23.00%

Quarterly revenue - Rate of surprise